��������

Dr. Sergei Shevchuk is the Senior Director of Quality Assurance and Quality Control at Neurona Therapeutics. He has more than 20 years of Quality Assurance and drug development experience in the biopharmaceutical industry. Prior to joining Neurona, Sergei was a Senior Director, Quality and Compliance at Principia Biopharma, a Sanofi company, where he led Quality Management System improvement efforts and the GMP Quality team. Prior to Principia, Sergei held positions within the quality organization at Gilead Sciences, managing teams in Quality Control, as well as in clinical and commercial Quality Assurance. Sergei holds an M.S. in organic chemistry from Odessa I.I. Mechnikov National University and Ph.D. in inorganic chemistry from A.V. Bogatsky Physico-Chemical Institute of the National Academy of Sciences of Ukraine.